Integrase Inhibitors
- Name
- Integrase Inhibitors
- Accession Number
- DBCAT001872
- Description
Compounds which inhibit or antagonize biosynthesis or actions of integrase.
- ATC Classification
- Drugs
Drug Drug Description Raltegravir An antiretroviral agent used for the treatment of HIV infections in conjunction with other antiretrovirals. Dolutegravir An antiviral agent used for the treatment of HIV-1 infections in combination with other antiretroviral agents. HIV Integrase Inhibitor HIV Integrase Inhibitor is under investigation in clinical trial NCT00397566 (A Multiple Ascending Dose Study of BMS-707035 in HIV-1 Infected Subjects). Elvitegravir An antiretroviral agent used in combination with other antiretrovirals for the treatment of HIV-1 infection in antiretroviral treatment-experienced adults. Cabotegravir An HIV-1 integrase inhibitor used for treatment and pre-exposure prophylaxis of HIV-1 infection. - Drugs & Drug Targets